메뉴 건너뛰기




Volumn 32, Issue 4, 2018, Pages e124-e126

Granuloma annulare associated with immune checkpoint inhibitors

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE INHIBITOR; DURVALUMAB; NIVOLUMAB; PEMBROLIZUMAB; STEROID; IMMUNOLOGIC FACTOR; IMMUNOLOGICAL ANTINEOPLASTIC AGENT;

EID: 85044277696     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.14617     Document Type: Letter
Times cited : (20)

References (8)
  • 1
    • 84962144656 scopus 로고    scopus 로고
    • Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor
    • Belum VR, Benhuri B, Postow MA et al. Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor. Eur J Cancer 2016; 60: 12–25.
    • (2016) Eur J Cancer , vol.60 , pp. 12-25
    • Belum, V.R.1    Benhuri, B.2    Postow, M.A.3
  • 2
    • 75249100054 scopus 로고    scopus 로고
    • Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
    • Wolchok JD, Neyns B, Linette G et al. Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study. Lancet Oncol 2010; 11: 155–164.
    • (2010) Lancet Oncol , vol.11 , pp. 155-164
    • Wolchok, J.D.1    Neyns, B.2    Linette, G.3
  • 3
    • 84976354836 scopus 로고    scopus 로고
    • Autoimmune bullous skin disorders with immune checkpoint inhibitors targeting PD-1 and PD-L1
    • Naidoo J, Schindler K, Querfeld C et al. Autoimmune bullous skin disorders with immune checkpoint inhibitors targeting PD-1 and PD-L1. Cancer Immunol Res 2016; 4: 383–389.
    • (2016) Cancer Immunol Res , vol.4 , pp. 383-389
    • Naidoo, J.1    Schindler, K.2    Querfeld, C.3
  • 4
    • 84960155371 scopus 로고    scopus 로고
    • Toxic epidermal necrolysis-like reaction with severe satellite cell necrosis associated with nivolumab in a patient with ipilimumab refractory metastatic melanoma
    • Nayar N, Briscoe K, Fernandez Penas P. Toxic epidermal necrolysis-like reaction with severe satellite cell necrosis associated with nivolumab in a patient with ipilimumab refractory metastatic melanoma. J Immunother (Hagerstown, Md.: 1997) 2016; 39: 149–152.
    • (2016) J Immunother (Hagerstown, Md.: 1997) , vol.39 , pp. 149-152
    • Nayar, N.1    Briscoe, K.2    Fernandez Penas, P.3
  • 5
    • 85017534907 scopus 로고    scopus 로고
    • Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
    • Birnbaum MR, Ma MW, Fleisig S et al. Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma. JAAD Case Rep 2017; 3: 208–211.
    • (2017) JAAD Case Rep , vol.3 , pp. 208-211
    • Birnbaum, M.R.1    Ma, M.W.2    Fleisig, S.3
  • 6
    • 84937161717 scopus 로고    scopus 로고
    • Granuloma annulare
    • Keimig EL. Granuloma annulare. Dermatol Clin 2015; 33: 315–329.
    • (2015) Dermatol Clin , vol.33 , pp. 315-329
    • Keimig, E.L.1
  • 7
    • 85015676111 scopus 로고    scopus 로고
    • Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options
    • Piette EW, Rosenbach M. Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options. J Am Acad Dermatol 2016; 75: 467–479.
    • (2016) J Am Acad Dermatol , vol.75 , pp. 467-479
    • Piette, E.W.1    Rosenbach, M.2
  • 8
    • 84964290544 scopus 로고    scopus 로고
    • Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes
    • Freeman-Keller M, Kim Y, Cronin H et al. Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes. Clin Cancer Res 2016; 22: 886–894.
    • (2016) Clin Cancer Res , vol.22 , pp. 886-894
    • Freeman-Keller, M.1    Kim, Y.2    Cronin, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.